Spero Therapeutics, Inc. (Nasdaq:SPRO)
Health Care/Life Sciences • Biotechnology
CIK 1701108
Company
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Address
675 Massachusetts Avenue
14th floor
Cambridge, Massachusetts 02139
675 Massachusetts Avenue
14th floor
Cambridge, Massachusetts 02139
Employees
35
35
Stock Info
Close
$1.7400
$1.7400
Day Range
1.6600 - 1.7501
1.6600 - 1.7501
52 Week Range
0.9900 - 1.9950
0.9900 - 1.9950
Average volume
205.09K
205.09K
Short Interest
564K (02/29/24)
564K (02/29/24)
% of Float Shorted
1.59%
1.59%
Market Cap
$87.98M
$87.98M
Revenue
$48.58M
$48.58M
Net Income
-$46.42M
-$46.42M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman Ankit A Mahadevia MD, MBA |
President, Chief Executive Officer & Director Satyavrat Shukla CFA, MBA |
Independent Director Frank E Thomas CPA |
Independent Director Scott T Jackson MBA |
Lead Independent Director Patrick Volkert Vink MD, MBA |
Independent Director Milind S Deshpande PhD |
Independent Director Kathleen Tregoning |
Independent Director Cynthia Smith MBA |
Independent Director John C Pottage Jr., MD |
SEC filings
Date | Form | Event |
---|---|---|
14 Nov, 2024 | 8-K | |
14 Nov, 2024 | 10-Q | |
14 Nov, 2024 | SC 13G/A | |
12 Nov, 2024 | 4 | |
29 Oct, 2024 | 8-K | |
10 Sep, 2024 | 8-K | |
29 Aug, 2024 | 4 | |
29 Aug, 2024 | 4 | |
29 Aug, 2024 | 4 | |
6 Aug, 2024 | 4 | |
5 Aug, 2024 | 10-Q | |
5 Aug, 2024 | S-8 | |
5 Aug, 2024 | 8-K | |
3 Jun, 2024 | 8-K | |
30 May, 2024 | 4 | |
30 May, 2024 | 4 | |
30 May, 2024 | 4 | |
30 May, 2024 | 4 | |
30 May, 2024 | 4 | |
30 May, 2024 | 4 | |
30 May, 2024 | 4 | |
30 May, 2024 | 4 | |
15 May, 2024 | 8-K | |
15 May, 2024 | 10-Q | |
16 Apr, 2024 | DEFA14A | |
16 Apr, 2024 | ARS | |
16 Apr, 2024 | DEF 14A | |
29 Mar, 2024 | 8-K | |
22 Mar, 2024 | EFFECT | |
20 Mar, 2024 | UPLOAD | |
20 Mar, 2024 | CORRESP | |
15 Mar, 2024 | S-8 | |
15 Mar, 2024 | S-3 | |
13 Mar, 2024 | 10-K | |
13 Mar, 2024 | 8-K | |
14 Feb, 2024 | SC 13G | |
9 Feb, 2024 | 8-K | CEO Change |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 144 | |
8 Jan, 2024 | 8-K | |
5 Jan, 2024 | 8-K | |
4 Jan, 2024 | 4 | |
2 Jan, 2024 | 8-K | |
15 Nov, 2023 | 3 | |
15 Nov, 2023 | 4 | |
13 Nov, 2023 | S-8 | |
13 Nov, 2023 | S-8 | |
13 Nov, 2023 | 10-Q | |
13 Nov, 2023 | 8-K | |
1 Nov, 2023 | 8-K | |
16 Oct, 2023 | 8-K/A | |
10 Oct, 2023 | 4 | |
10 Oct, 2023 | 8-K | |
10 Oct, 2023 | 4 | |
10 Oct, 2023 | 4 | |
10 Oct, 2023 | 4 | |
10 Oct, 2023 | 4 | |
10 Oct, 2023 | 4 | |
10 Oct, 2023 | 4 | |
10 Oct, 2023 | 4 | |
15 Sep, 2023 | 4 | |
1 Sep, 2023 | DEF 14A | |
1 Sep, 2023 | ARS | |
30 Aug, 2023 | 4 | |
30 Aug, 2023 | 4 | |
30 Aug, 2023 | 4 | |
30 Aug, 2023 | 4 | |
29 Aug, 2023 | 144 | |
22 Aug, 2023 | PRE 14A | |
10 Aug, 2023 | 10-Q | |
10 Aug, 2023 | S-8 | |
10 Aug, 2023 | 8-K | |
3 Aug, 2023 | 4 | |
31 Jul, 2023 | 8-K | |
24 Jul, 2023 | 3 | |
14 Jun, 2023 | 4 | |
14 Jun, 2023 | 8-K | CEO Change |
11 May, 2023 | 8-K | |
11 May, 2023 | 10-Q | |
30 Mar, 2023 | 10-K | |
30 Mar, 2023 | 8-K | |
30 Mar, 2023 | S-8 | |
14 Feb, 2023 | SC 13G/A | |
14 Feb, 2023 | SC 13G/A | |
6 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
3 Feb, 2023 | 4 | |
1 Feb, 2023 | 8-K | |
20 Jan, 2023 | SC 13D/A | |
19 Jan, 2023 | CT ORDER | |
9 Jan, 2023 | 8-K | |
5 Jan, 2023 | 4 | |
5 Jan, 2023 | 4 | |
15 Nov, 2022 | D | |
14 Nov, 2022 | 3 | |
14 Nov, 2022 | 10-Q | |
14 Nov, 2022 | SC 13D/A | |
14 Nov, 2022 | S-8 | |
14 Nov, 2022 | 8-K | |
8 Nov, 2022 | 8-K | |
3 Oct, 2022 | SC 13G/A | |
26 Sep, 2022 | 4 | |
22 Sep, 2022 | 8-K | |
19 Sep, 2022 | 4 | |
19 Sep, 2022 | 4 | |
19 Sep, 2022 | 4 | |
19 Sep, 2022 | 4 | |
19 Sep, 2022 | 4 | |
19 Sep, 2022 | 8-K | |
19 Sep, 2022 | 4 | |
19 Sep, 2022 | 4 | |
14 Sep, 2022 | 3 | |
14 Sep, 2022 | 4 | |
6 Sep, 2022 | 8-K | |
30 Aug, 2022 | 4 | |
10 Aug, 2022 | 8-K | |
10 Aug, 2022 | 10-Q | |
5 Aug, 2022 | DEFA14A | |
5 Aug, 2022 | DEF 14A | |
8 Jul, 2022 | SC 13G | |
1 Jul, 2022 | 8-K | |
27 Jun, 2022 | 8-K | |
7 Jun, 2022 | 8-K | |
16 May, 2022 | 8-K | |
16 May, 2022 | 10-Q | |
3 May, 2022 | 8-K | |
28 Apr, 2022 | 4 | |
7 Apr, 2022 | 8-K | |
31 Mar, 2022 | 10-K | |
31 Mar, 2022 | 4 | |
31 Mar, 2022 | 8-K | |
16 Mar, 2022 | 4 | |
9 Mar, 2022 | SC 13G/A | |
2 Mar, 2022 | 4 | |
23 Feb, 2022 | 4 | |
16 Feb, 2022 | 8-K | |
14 Feb, 2022 | SC 13G/A | |
14 Feb, 2022 | SC 13G/A | |
3 Feb, 2022 | 4 | |
3 Feb, 2022 | 4 | |
3 Feb, 2022 | 4 | |
3 Feb, 2022 | SC 13G/A | |
3 Feb, 2022 | 4 | |
3 Feb, 2022 | 4 | |
3 Feb, 2022 | 4 | |
1 Feb, 2022 | 4 | |
26 Jan, 2022 | 4 | |
25 Jan, 2022 | 8-K | |
25 Jan, 2022 | SC 13G/A | |
20 Jan, 2022 | 4 | |
19 Jan, 2022 | 8-K | |
12 Jan, 2022 | 4 | |
7 Jan, 2022 | 4 | |
7 Jan, 2022 | 4 | |
7 Jan, 2022 | 4 | |
4 Jan, 2022 | 8-K | |
3 Jan, 2022 | 4 | |
29 Dec, 2021 | 4 | |
16 Dec, 2021 | CT ORDER | |
12 Nov, 2021 | 4 | |
10 Nov, 2021 | 10-Q | |
10 Nov, 2021 | 8-K | |
2 Nov, 2021 | 4 | |
28 Oct, 2021 | 8-K | |
14 Oct, 2021 | 3 | |
12 Oct, 2021 | 8-K | |
4 Oct, 2021 | 4 | |
30 Sep, 2021 | 8-K | |
20 Sep, 2021 | S-8 | |
16 Sep, 2021 | SC 13D/A | |
15 Sep, 2021 | 4 | |
10 Sep, 2021 | 4 | |
1 Sep, 2021 | 4 | |
30 Aug, 2021 | 4 | |
30 Aug, 2021 | 4 | |
30 Aug, 2021 | 8-K | |
30 Aug, 2021 | 4 | |
30 Aug, 2021 | 4 | |
30 Aug, 2021 | 4 | |
30 Aug, 2021 | 4 | |
27 Aug, 2021 | 4 | |
24 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
18 Aug, 2021 | 8-K | |
18 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
5 Aug, 2021 | 10-Q | |
5 Aug, 2021 | 8-K | |
14 Jul, 2021 | D | |
9 Jul, 2021 | SC 13G | |
6 Jul, 2021 | DEF 14A | |
1 Jul, 2021 | 8-K | |
25 Jun, 2021 | PRE 14A | |
6 May, 2021 | 8-K | |
6 May, 2021 | 10-Q | |
29 Mar, 2021 | EFFECT | |
24 Mar, 2021 | CORRESP | |
23 Mar, 2021 | 10-K/A | |
17 Mar, 2021 | UPLOAD | |
11 Mar, 2021 | 10-K | |
11 Mar, 2021 | S-8 | |
11 Mar, 2021 | 8-K | |
11 Mar, 2021 | S-3 | |
16 Feb, 2021 | SC 13D/A | |
16 Feb, 2021 | SC 13G/A | |
16 Feb, 2021 | SC 13G/A | |
10 Feb, 2021 | SC 13G/A | |
10 Feb, 2021 | 4 | |
5 Feb, 2021 | 8-K | |
4 Feb, 2021 | 4 | |
3 Feb, 2021 | 4 | |
3 Feb, 2021 | 4 | |
3 Feb, 2021 | 4 | |
3 Feb, 2021 | 4 | |
2 Feb, 2021 | SC 13G | |
2 Feb, 2021 | SC 13G/A | |
19 Jan, 2021 | 8-K | |
6 Jan, 2021 | 4 | |
6 Jan, 2021 | 4 | |
6 Jan, 2021 | 4 | |
6 Jan, 2021 | 4 | |
5 Jan, 2021 | 4 | |
5 Jan, 2021 | 3 |
Last update:2024-03-12 12:02:51.163335
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.